Mallory Hackett
As indicated by the FDA, the system can estimate pulse rate, heart rate, respiratory rate and/or breathing rates.
GE Research has received a grant from the NIH to develop sensors that can be embedded into mobile devices to detect COVID-19 particles on their surfaces.
The digital therapeutic is designed to treat children ages 8 to 12 with ADHD, but the two studies announced this week will focus on an adult population.
Starting this month, eligible Fitbit Sense users can participate in the study, which will look into how pulse arrival time can be used to measure blood pressure.
Also: Pre-conception genetic-testing startup Orchid completes seed round, and Canvas Medical scores $17M for its physician practice platform.
The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company.
Verizon introduces BlueJeans Telehealth platform for providers
Rock Health reports $6.7 billion in digital health funding in Q1, a majority of which comes from rounds worth more than $100 million.